| Autor: |
Johnson, D W, Herzig, K A, Gissane, R, Campbell, S B, Hawley, C M, Isbel, N M |
| Zdroj: |
Nephrology Dialysis Transplantation; September 2001, Vol. 16 Issue: 9 p1879-1884, 6p |
| Abstrakt: |
Concomitant iron supplementation is required in the great majority of erythropoietin (Epo)-treated patients with end-stage renal failure. Intravenous (i.v.) iron supplementation has been demonstrated to be superior to oral iron therapy in Epo-treated haemodialysis patients, but comparative data in iron-replete peritoneal dialysis (PD) patients are lacking. |
| Databáze: |
Supplemental Index |
| Externí odkaz: |
|
